Search Results
12 items found for "Patrick Giguere"
- Ep 89 with Dr. Patrick Sexton
Patrick Sexton About Dr. Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council Patrick Sexton on the web CCeMMP Monash University Dr.
- Ep 89 with Dr. Patrick Sexton
Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council Patrick Sexton on the web CCeMMP Monash University Dr.
- GPCR Retreat Committee 2023 | Dr. GPCR Ecosystem
Patrick Giguère Dr.
- Biased agonism at the GLP-1 receptor: from structure to animal models of disease
to animal models of disease Date & Time Friday, November 3rd / 11:05 AM Abstract Coming Soon About Patrick Sexton " Patrick Sexton is a NHMRC Senior Principal Research Fellow and Director, ARC Centre for Cryo-electron Sexton is also a co-founder of Septerna Inc. " Patrick Sexton on the web CCeMMP Monash University Dr.
- Ep 74 with Dr. Daniel Wacker
I then obtained an M.Sc. at the University in Munich working e.g. in the lab of Patrick Cramer .
- Ep 74 with Dr. Daniel Wacker
I then obtained an M.Sc. at the University in Munich working e.g. in the lab of Patrick Cramer .
- Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
Verhallen , Mirre De Bondt , Lotte Vanbrabant , Stef Brusselmans , Erik Martens , Dominique Schols , Patrick
- Dr. GPCR Summit 2021 Live Talks
Patrick M. Sexton September 17, 2021 at 9:00:00 PM Learn More >> Meet Dr.
- GPCR Retreat Schedule 2023
November 3rd / 11:05 AM Biased agonism at the GLP-1 receptor: from structure to animal models of disease Patrick
- 20-08 Dr GPCR Newsletter
This will be based out of Monash Institute of Pharmaceutical Sciences and will be led by Professor Patrick
- 22-02 Dr GPCR Newsletter
Septerna emerges with $100M to use allosterism as a means to drug target GPCRs with Bob Lefkowitz, Patrick
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
his postdoctoral studies with Allan Bernstein at the Lunenfeld Research Institute in Toronto and with Patrice